A new Drug Trials Snapshot for GENVOYA is now available. GENVOYA is a drug for the treatment of HIV-1 infection in adults and children 12 years of age and older. It is a fixed-dose combination tablet, which means GENVOYA includes more than one drug combined in a single tablet.
Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.
See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.
No hay comentarios:
Publicar un comentario